ES2163478T3 - Procedimiento de preparacion de composiciones cosmeticas o farmaceuticas que contienen liposomas. - Google Patents

Procedimiento de preparacion de composiciones cosmeticas o farmaceuticas que contienen liposomas.

Info

Publication number
ES2163478T3
ES2163478T3 ES95400322T ES95400322T ES2163478T3 ES 2163478 T3 ES2163478 T3 ES 2163478T3 ES 95400322 T ES95400322 T ES 95400322T ES 95400322 T ES95400322 T ES 95400322T ES 2163478 T3 ES2163478 T3 ES 2163478T3
Authority
ES
Spain
Prior art keywords
aryl
halogen
cosmetic
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95400322T
Other languages
English (en)
Inventor
Jean-Luc Dubois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2163478T3 publication Critical patent/ES2163478T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A LAS COMPOSICIONES COSMETICAS O FARMACEUTICAS QUE COMPRENDE LIPOSOMAS QUE CONTIENEN UN COMPUESTO ACTIVO DE FORMULA (I) EN LA QUE: R1 REPRESENTA UN RADICAL CIANO O NITRO O UN ATOMO DE HALOGENO, R2 REPRESENTA UN RADICAL TRIFLUOROMETILO O UN ATOMO DE HALOGENO, EL GRUPO -A-B- ES POR EJEMPLO EN EL QUE X REPRESENTA UN ATOMO DE OXIGENO, R3 ES POR EJEMPLO UN ATOMO DE HIDROGENO O UN RADICAL ALKILO E Y REPRESENTA UN ATOMO DE OXIGENO O DE AZUFRE O UN RADICAL =NH.
ES95400322T 1994-02-16 1995-02-15 Procedimiento de preparacion de composiciones cosmeticas o farmaceuticas que contienen liposomas. Expired - Lifetime ES2163478T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401755A FR2716110B1 (fr) 1994-02-16 1994-02-16 Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.

Publications (1)

Publication Number Publication Date
ES2163478T3 true ES2163478T3 (es) 2002-02-01

Family

ID=9460135

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95400322T Expired - Lifetime ES2163478T3 (es) 1994-02-16 1995-02-15 Procedimiento de preparacion de composiciones cosmeticas o farmaceuticas que contienen liposomas.

Country Status (16)

Country Link
US (1) US6162444A (es)
EP (1) EP0671156B1 (es)
JP (1) JPH07309754A (es)
KR (1) KR100407902B1 (es)
CN (1) CN1149971C (es)
AT (1) ATE207337T1 (es)
AU (1) AU701344B2 (es)
CA (1) CA2141506A1 (es)
DE (1) DE69523356T2 (es)
DK (1) DK0671156T3 (es)
ES (1) ES2163478T3 (es)
FR (1) FR2716110B1 (es)
HU (1) HU218578B (es)
PT (1) PT671156E (es)
RU (1) RU2131731C1 (es)
ZA (1) ZA951281B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289939B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
US6132582A (en) 1998-09-14 2000-10-17 The Perkin-Elmer Corporation Sample handling system for a multi-channel capillary electrophoresis device
ES2258342T3 (es) * 1998-10-23 2006-08-16 Aventis Pharma S.A. Preparaciones para aplicacion topica de sustancias que tienen efecto antiandrogenico.
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2001288213B2 (en) 2000-06-28 2005-04-14 Bristol-Myers Squibb Company Selective androgen receptor modulators and methods for their identification, design and use
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (en) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
WO2003053358A2 (en) 2001-12-19 2003-07-03 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
US6875438B2 (en) * 2002-04-27 2005-04-05 Aventis Pharma Deutschland Gmbh Preparations for topical administration of substances having antiandrogenic activity
DE10218963A1 (de) * 2002-04-27 2003-11-20 Aventis Pharma Gmbh Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
US20110142922A1 (en) * 2002-04-30 2011-06-16 Ferndale Ip, Inc. Stabilized composition and method for dermatological treatment
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
EP1358872B1 (de) * 2002-04-30 2008-03-12 Cognis IP Management GmbH Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
US7074418B2 (en) * 2002-11-18 2006-07-11 Changaris David G Conjugated fatty acid based emulsion and methods for preparing and using same
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
US7407623B2 (en) * 2003-12-09 2008-08-05 Ge Betz, Inc. Steam condensate corrosion inhibitor compositions and methods
PT1802277E (pt) * 2004-10-18 2010-04-01 Polymun Scient Immunbio Forsch Composição lipossomal contendo um ingrediente activo para relaxar a musculatura lisa, produção desta composição e a sua aplicação terapêutica
EP1912679A4 (en) * 2005-06-15 2009-07-29 Massachusetts Inst Technology AMINOUS LIPIDS AND ITS USES
TW201111378A (en) 2009-09-11 2011-04-01 Bayer Schering Pharma Ag Substituted (heteroarylmethyl) thiohydantoins
RU2503446C2 (ru) * 2012-02-07 2014-01-10 Алексей Валентинович Одинцов Средство для роста волос (варианты) и способ лечения облысения
CN103965112A (zh) * 2014-05-13 2014-08-06 上海孚一生物科技有限公司 一种具有抗雄激素活性的化合物、制备方法及其应用
AU2019387367A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Diarylhydantoin compounds and methods of use thereof
CN113024513A (zh) * 2021-03-22 2021-06-25 中国药科大学 新型雄激素受体降解剂、制备方法和医药用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476087A1 (fr) 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2627385B3 (fr) * 1988-02-23 1991-08-23 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
FR2631234B1 (fr) 1988-05-10 1990-09-14 Dior Christian Parfums Composition cosmetique ou dermatologique, notamment a action amincissante ou anti-cellulitique contenant des extraits de cola sous forme libre ou sous forme liposomale
US5204105A (en) * 1990-04-10 1993-04-20 Chanel, Inc. Cosmetic composition
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
DE4207481A1 (de) * 1992-03-10 1993-09-16 Bayer Ag Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung
US5358752A (en) * 1993-02-23 1994-10-25 Norac Technologies Inc. Skin care composition

Also Published As

Publication number Publication date
FR2716110A1 (fr) 1995-08-18
HU218578B (hu) 2000-10-28
KR950031033A (ko) 1995-12-18
FR2716110B1 (fr) 1996-04-05
US6162444A (en) 2000-12-19
CN1149971C (zh) 2004-05-19
ATE207337T1 (de) 2001-11-15
JPH07309754A (ja) 1995-11-28
RU2131731C1 (ru) 1999-06-20
RU95101833A (ru) 1997-02-27
EP0671156A1 (fr) 1995-09-13
DK0671156T3 (da) 2002-02-04
EP0671156B1 (fr) 2001-10-24
AU1227795A (en) 1995-08-24
PT671156E (pt) 2002-03-28
ZA951281B (en) 1996-02-16
DE69523356T2 (de) 2002-07-11
KR100407902B1 (ko) 2004-03-09
HU9500454D0 (en) 1995-04-28
DE69523356D1 (de) 2001-11-29
CA2141506A1 (fr) 1995-08-17
HUT72021A (en) 1996-03-28
CN1112416A (zh) 1995-11-29
AU701344B2 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
ES2163478T3 (es) Procedimiento de preparacion de composiciones cosmeticas o farmaceuticas que contienen liposomas.
DE69327438D1 (de) Therapeutische Mittel für die Parkinsonsche Krankheit
DE69113604D1 (de) Quinoloncarbonsäurederivat.
ATE179711T1 (de) 1,2-substituierte 1h-imidazo(4,5-c>chinolin-4- amine
DE69029627T2 (de) 4-(1'-Oxocyclohex-2'-yl)azetidin-2-on-Derivate
HUP0102793A2 (hu) Agydaganat kezelésére szolgáló kinazolinok és ezeket tartalmazó gyógyszerkészítmények
DE69500542T2 (de) 11,21-Bisphenyl-19-nor-pregnan Derivate
DE69500511T2 (de) Phosphatdiester zur Behandlung von proliferativen Erkrankungen der Epidermis
HUT66410A (en) Benzomorphan derivatives and pharmaceutical compositions containing them
DE69218816D1 (de) N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
ES2180975T3 (es) Derivados de cicloalquilaminometilpirrolidina.
TW330147B (en) Halogenobenzimidazoles, their preparation processes and their use
NZ509327A (en) Alpha-amino acid phenyl ester derivatives for use in general anaesthesia
DE69810332D1 (de) Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung
HUP0400916A2 (hu) Transzdermális terápiás készítmény a gyapjú- és hajhullás megelőzésére és/vagy kezelésére
HUP0202237A2 (hu) Amin, módosított pszeudomicin vegyületek, azokat tartalmazó gyógyászati készítmény és alkalmazásuk

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 671156

Country of ref document: ES